Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditis

Ann Epidemiol. 2021 Feb:54:29-37. doi: 10.1016/j.annepidem.2020.09.008. Epub 2020 Sep 18.

Abstract

Purpose: Prognostic studies derived from samples of patients managed in tertiary hospitals are subject to referral bias. We aimed to characterize this bias using the example of infective endocarditis.

Methods: We analyzed data from a French population-based cohort, which included 497 patients with infective endocarditis. Patients were admitted directly to a tertiary hospital (Group T), admitted to a non-tertiary hospital and referred to a tertiary hospital (Group NTT) or not (Group NT). We compared patients' characteristics, survival rates and prognostic factors between groups.

Results: Compared with Group T (n = 291), NTT patients (n = 144) were more often males (81.3% vs. 72.5%; P = .046), injection drug users (9.7% vs. 4.5%; P = .033), and had more frequent surgical indications (78.5% vs. 64.3%; P = .003). Compared with Group NT (n = 62), NTT patients were more often males (81.3% vs. 67.7%; P = .034) and had surgical indications more often (78.5% vs. 19.4%; P < .001). One-year survival was higher in NTT + T patients than in NT patients (73.0% vs. 56.1%; P = .01). Prognostic factors and hazard ratios estimates varied across groups.

Conclusions: When derived from samples mixing patients admitted directly and those referred to tertiary hospitals, validity of characteristics description, survival estimates, and hazard ratios is threatened by referral bias.

Keywords: Infective endocarditis; Prognostic factors; Referral bias; Selection bias; Survival; Tertiary hospitals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bias
  • Cohort Studies
  • Endocarditis* / epidemiology
  • Endocarditis* / therapy
  • Female
  • France / epidemiology
  • Humans
  • Male
  • Prognosis
  • Referral and Consultation* / statistics & numerical data